arginine has been researched along with Drug Withdrawal Symptoms in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (56.25) | 18.2507 |
2000's | 10 (31.25) | 29.6817 |
2010's | 4 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, IJ; Kim, SC; Lee, BH; Wu, Y; Xu, Y; Yang, CH; Zhang, J; Zhao, R; Zhao, Z | 1 |
Morgenstern, R; Netzhammer, N; Seidemann, T; Spies, C; Wernecke, KD | 1 |
Dandekar, MP; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
Dandekar, MP; Kokare, DM; Singru, PS; Subhedar, NK; Upadhya, MA | 1 |
Chopde, CT; Kotagale, NR; Patel, MR; Shelkar, GP; Taksande, BG; Ugale, RR | 1 |
Bleich, S; Frieling, H; Haschemi-Nassab, M; Hillemacher, T; Kornhuber, J; Leitmeier, V; Rhein, M | 1 |
Jain, NK; Kulkarni, SK; Singh, VP | 1 |
Cao, JL; Gu, J; Yang, GD; Zeng, YM; Zhang, YH; Zhou, WH | 1 |
De Witte, P; Dravolina, O; Lallemand, F; Ward, RJ | 1 |
Boissoneault, J; Bruijnzeel, AW; Isaac, S; Prado, M; Rylkova, D; Shah, HP | 1 |
Cappendijk, SL; de Vries, R; Dzoljic, MR | 1 |
Kimes, AS; London, ED; Vaupel, DB | 3 |
Buccafusco, JJ; Shuster, L; Terry, AV | 1 |
Adams, ML; Cicero, TJ; Kalicki, JM; Meyer, ER | 1 |
Ciszewska, G; Kolesnikov, YA; Pasternak, GW; Pick, CG | 1 |
Badrov, N; Futo, J; Moss, J; Shay, J | 1 |
Cuéllar, B; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA | 1 |
Dunbar, S; Yaksh, TL | 1 |
Babey, AM; Kolesnikov, YA; Pasternak, GW | 1 |
Claunch, AE; Corbit, BP; Jones, JA; Kacher, D; Lake, JR; Malin, DH; Moon, WD; Morel, J; Smith, DA; Stevens, PA; Webb, SL | 1 |
Dambisya, YM; Lee, TL | 1 |
McNeill, JR; Talom, RT | 1 |
Erden, BF; Kayaalp, SO; Tapanyigit, EE; Uzbay, IT | 1 |
Misawa, M; Shimizu, N; Suzuki, T; Tsuda, M; Yajima, Y | 1 |
Akbarloo, N; Dehpour, AR; Ghafourifar, P | 1 |
Cervigni, C; Dazzi, D; Negro, R; Pezzarossa, A; Vescovi, PP | 1 |
Dahchour, A; De Witte, P | 1 |
Uzbay, IT | 1 |
Abou Zeit-Har, MS; Afify, EA; Daabees, TT; Gabra, BH | 1 |
Fayaz-Dastgerdi, M; Homayoun, H; Khavandgar, S; Zarrindast, MR | 1 |
3 review(s) available for arginine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
Topics: Animals; Arginine; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rats; Substance Withdrawal Syndrome | 1995 |
Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
Topics: Animals; Arginine; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Morphine; Narcotics; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1995 |
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Blood Pressure; Clonidine; Depression, Chemical; Enzyme Inhibitors; Heart Rate; Indazoles; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Ornithine; Substance Withdrawal Syndrome | 1995 |
29 other study(ies) available for arginine and Drug Withdrawal Symptoms
Article | Year |
---|---|
Involvement of amygdaloid neuropeptide Y in the anxiolytic effects of acupuncture during ethanol withdrawal in rats.
Topics: Acupuncture Therapy; Amygdala; Animals; Anxiety; Arginine; Benzazepines; Cyclic AMP Response Element-Binding Protein; Ethanol; Male; Maze Learning; Neuropeptide Y; Phosphorylation; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2014 |
Influence of Volatile Anesthesia on the Release of Glutamate and other Amino Acids in the Nucleus Accumbens in a Rat Model of Alcohol Withdrawal: A Pilot Study.
Topics: Amino Acids; Anesthesia, Inhalation; Animals; Arginine; Aspartic Acid; Desflurane; Disease Models, Animal; Feeding Behavior; gamma-Aminobutyric Acid; Glutamic Acid; Isoflurane; Male; Microdialysis; Nucleus Accumbens; Pilot Projects; Rats, Wistar; Substance Withdrawal Syndrome; Time Factors; Volatilization | 2017 |
Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Topics: Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Eating; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substance Withdrawal Syndrome; Time Factors | 2009 |
Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Topics: Analgesics, Opioid; Animals; Arginine; Behavior, Animal; Drug Tolerance; Hyperalgesia; Male; Morphine; Neuropeptide Y; Pain Measurement; Peripheral Nervous System Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sciatic Nerve; Substance Withdrawal Syndrome | 2009 |
Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
Topics: Agmatine; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Biguanides; Brain; Clonidine; Dose-Response Relationship, Drug; Eflornithine; Ethanol; Guanidines; Imidazoles; Imidazoline Receptors; Ligands; Maze Learning; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2010 |
Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.
Topics: Adult; Alcoholism; Arginine; Diagnostic and Statistical Manual of Mental Disorders; Germany; Homocysteine; Humans; Hyperhomocysteinemia; International Classification of Diseases; Male; Middle Aged; Nitric Oxide Synthase; Pilot Projects; Prospective Studies; Risk Factors; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Vascular Diseases | 2012 |
Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
Topics: Animals; Arginine; Body Weight; Cyclic GMP; Depression, Chemical; Diarrhea; Dopamine; Drug Interactions; Drug Tolerance; Female; Fluoxetine; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome | 2003 |
[Application of combination of capillary electrophoresis with laser-induced fluorescence: measurement of glutamate and arginine in PAG microdialytes of conscions morphine-withdrawal rats].
Topics: Animals; Arginine; Electrophoresis, Capillary; Fluorescence; Glutamic Acid; Lasers; Microdialysis; Morphine; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2003 |
Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Arginine; Brain Chemistry; Central Nervous System Depressants; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Ethanol; Extracellular Fluid; Glutamic Acid; Male; Microdialysis; Nicotine; Nicotinic Agonists; Nitric Oxide; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Topics: Animals; Arginine; Brain; Drug Implants; Electric Stimulation; Electrodes, Implanted; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2008 |
Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Behavior, Animal; Diarrhea; Male; Mice; Morphine Dependence; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Substance Withdrawal Syndrome | 1993 |
Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Male; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Weight Loss | 1993 |
Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Topics: Animals; Arginine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Morphine Dependence; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Structure-Activity Relationship; Substance Withdrawal Syndrome | 1995 |
Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Male; Morphine; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1993 |
Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acid Oxidoreductases; Analgesics; Animals; Arginine; Drug Administration Schedule; Drug Tolerance; Male; Mice; Mice, Inbred Strains; Morphine; Nitric Oxide Synthase; Nitroarginine; Pyrrolidines; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors | 1993 |
Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery.
Topics: Animals; Arginine; Basilar Artery; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroarginine; Ovariectomy; Rabbits; Serotonin; Substance Withdrawal Syndrome; Superovulation; Testosterone | 1994 |
Correlation between brain nitric oxide synthase activity and opiate withdrawal.
Topics: Animals; Arginine; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Injections, Subcutaneous; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Stereoisomerism; Substance Withdrawal Syndrome | 1996 |
Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
Topics: Animals; Arginine; Drug Tolerance; Injections, Spinal; Morphine; Morphine Dependence; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pain Measurement; Rats; Spinal Cord; Substance Withdrawal Syndrome | 1996 |
Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF.
Topics: Animals; Arginine; Cerebral Ventricles; Enzyme Inhibitors; Injections, Intraventricular; Male; Narcotic Antagonists; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stereotyped Behavior; Substance Withdrawal Syndrome | 1996 |
Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
Topics: Animals; Arginine; Drug Interactions; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Pain Measurement; Substance Withdrawal Syndrome | 1996 |
Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
Topics: Animals; Antihypertensive Agents; Arginine; Arginine Vasopressin; Blood Pressure; Enzyme Inhibitors; Hypertension; Male; Nitric Oxide; Nitroarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Vasoconstrictor Agents | 1997 |
Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats.
Topics: Acoustic Stimulation; Alcoholism; Animals; Arginine; Behavior, Animal; Enzyme Inhibitors; Ethanol; Indazoles; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Seizures; Substance Withdrawal Syndrome | 1997 |
Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice.
Topics: Animals; Arginine; Diazepam; Enzyme Inhibitors; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Pentylenetetrazole; Seizures; Substance Withdrawal Syndrome | 1998 |
Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis.
Topics: Acute Disease; Animals; Arginine; Behavior, Animal; Bile Ducts; Cholestasis; Enzyme Inhibitors; Male; Mice; Naloxone; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Reaction Time; Substance Withdrawal Syndrome | 1998 |
Effects of alcohol consumption and accompanying diet on metabolic response to arginine in chronic alcoholics.
Topics: Adult; Alcohol Drinking; Alcoholism; Arginine; Blood Glucose; Central Nervous System Depressants; Ethanol; Female; Food, Formulated; Glucagon; Humans; Insulin; Male; Substance Withdrawal Syndrome | 1999 |
Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats.
Topics: Alcoholism; Animals; Arginine; Central Nervous System Depressants; Ethanol; gamma-Aminobutyric Acid; Glutamic Acid; Male; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Taurine | 2000 |
L-NAME precipitates catatonia during ethanol withdrawal in rats.
Topics: Acoustic Stimulation; Alcohol Drinking; Animals; Arginine; Catatonia; Central Nervous System Depressants; Enzyme Inhibitors; Ethanol; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Seizures; Substance Withdrawal Syndrome | 2001 |
Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
Topics: Animals; Arginine; Catalepsy; Enzyme Inhibitors; Fever; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Substance Withdrawal Syndrome | 2001 |
The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arginine; Clonidine; Enzyme Inhibitors; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Substance Withdrawal Syndrome; Yohimbine | 2002 |